#rarediseases — Public Fediverse posts

https://www.europesays.com/ch/119426/ Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA) #CellAndGeneTherapy #Neuroscience #Novartis #RareDiseases #ReimagineMedicine

Italy’s $10 Billion Pharma Family Makes A U.S. Power Move

F or more than 100 years, the billionaire Angelini family had been content to run a largely European…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #America #angelinipharma #catalystacquisition #epilepsydrugs #familybusiness #forbesbillionaires #italianbusinesses #Italiandrugbillionaires #rarediseases #Sergiomarullodicondojanni #theapaolaangelini #UnitedStatesofAmerica
https://www.newsbeep.com/us/819879/

Italy’s $10 Billion Pharma Family Makes A U.S. Power Move

F or more than 100 years, the billionaire Angelini family had been content to run a largely European…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #America #angelinipharma #catalystacquisition #epilepsydrugs #familybusiness #forbesbillionaires #italianbusinesses #Italiandrugbillionaires #rarediseases #Sergiomarullodicondojanni #theapaolaangelini #UnitedStatesofAmerica
https://www.newsbeep.com/us/819879/

Italy’s $10 Billion Pharma Family Makes A U.S. Power Move

F or more than 100 years, the billionaire Angelini family had been content to run a largely European…
#Italy #Europe #Europa #EU #angelinipharma #catalystacquisition #epilepsydrugs #familybusiness #forbesbillionaires #italianbusinesses #Italiandrugbillionaires #rarediseases #Sergiomarullodicondojanni #theapaolaangelini
https://www.europesays.com/italy/41334/

Sanofi (ENXTPA:SAN) On TD Cowen Spotlight And The Case For A Higher Valuation

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply…
#France #FR #Europe #EU #Sanofi #Cowen #fairvalue #immunology #individualinvestors #rarediseases
https://www.europesays.com/france/67000/

Sanofi (ENXTPA:SAN) On TD Cowen Spotlight And The Case For A Higher Valuation

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply…
#France #FR #Europe #EU #Sanofi #Cowen #fairvalue #immunology #individualinvestors #rarediseases
https://www.europesays.com/france/66974/

https://www.europesays.com/uk/1149251/ EU regulators offer post-mortem of Tavneos withdrawal decision #Amgen #AutoimmuneDiseases #ChemoCentryx #CHMPRecommendation #ClinicalData #CSL #DrugSafety #EU #Europe #European #EuropeanCommission #EuropeanMedicinesAgency #EuropeanUnion #FiercePharmaHomepage #pharma #RareDiseases #Tavneos

Tavneos trial flagged for ‘serious breaches’ of protocol as EU regulators dissect market withdrawal decision

With the European Union formally reversing its marketing authorization for rare disease med Tavneos last week, regulators from…
#Europe #EU #Amgen #Autoimmunediseases #ChemoCentryx #CHMPrecommendation #clinicaldata #CSL #drugsafety #EuropeanCommission #EuropeanMedicinesAgency #EuropeanUnion #FiercePharmaHomepage #Pharma #rarediseases #TAVNEOS
https://www.europesays.com/europe/116043/

Shane the Gamer: Belgian Gamer Michiel Vandeweert Dies at 28, Doubling Progeria Life Expectancy. “Belgian content creator and gamer Michiel Vandeweert has died at 28, more than twice as long as doctors expected when he was diagnosed as a child with progeria, the ultra-rare genetic disorder that causes rapid aging.”

Shane the Gamer: Belgian Gamer Michiel Vandeweert Dies at 28, Doubling Progeria Life Expectancy. “Belgian content creator and gamer Michiel Vandeweert has died at 28, more than twice as long as doctors expected when he was diagnosed as a child with progeria, the ultra-rare genetic disorder that causes rapid aging.”

Shane the Gamer: Belgian Gamer Michiel Vandeweert Dies at 28, Doubling Progeria Life Expectancy. “Belgian content creator and gamer Michiel Vandeweert has died at 28, more than twice as long as doctors expected when he was diagnosed as a child with progeria, the ultra-rare genetic disorder that causes rapid aging.”

Shane the Gamer: Belgian Gamer Michiel Vandeweert Dies at 28, Doubling Progeria Life Expectancy. “Belgian content creator and gamer Michiel Vandeweert has died at 28, more than twice as long as doctors expected when he was diagnosed as a child with progeria, the ultra-rare genetic disorder that causes rapid aging.”

Shane the Gamer: Belgian Gamer Michiel Vandeweert Dies at 28, Doubling Progeria Life Expectancy. “Belgian content creator and gamer Michiel Vandeweert has died at 28, more than twice as long as doctors expected when he was diagnosed as a child with progeria, the ultra-rare genetic disorder that causes rapid aging.”

Social Security Just Added 14 Rare Diseases to Its Fast-Track List — What It Means for You

Full story 👇

Learn more: https://www.earthinsider.in/2026/08/social-security-added-14-conditions.html

#EarthInsider #EarthInsiderNews #EINews #US #America #USNews #SocialSecurity #DisabilityBenefits #RareDiseases #BreakingNews #Trending #NewsAlert

Sanofi experiencing shortage of two Pompe disease drugs

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He…
#France #FR #Europe #EU #Sanofi #biotechnology #Pharmaceuticals #rarediseases #STAT+
https://www.europesays.com/france/63252/

This August, we're launching our #SummerOfScience series again! Stay tuned to hear about our most impactful stories from the past year.
First up is the launch of Screen4Care's tools to help diagnose #RareDiseases earlier and faster.
👶 A TREAT panel for testing newborns genetically for rare diseases using just a few drops of blood from a heel prick
📱 An app to reliably track a patients' symptoms as a diagnostic aide
👉 https://link.europa.eu/GYhXKX
#IHITransformingHealth #HorizonEU #HorizonEurope

This August, we're launching our #SummerOfScience series again! Stay tuned to hear about our most impactful stories from the past year.
First up is the launch of Screen4Care's tools to help diagnose #RareDiseases earlier and faster.
👶 A TREAT panel for testing newborns genetically for rare diseases using just a few drops of blood from a heel prick
📱 An app to reliably track a patients' symptoms as a diagnostic aide
👉 https://link.europa.eu/GYhXKX
#IHITransformingHealth #HorizonEU #HorizonEurope

This August, we're launching our #SummerOfScience series again! Stay tuned to hear about our most impactful stories from the past year.
First up is the launch of Screen4Care's tools to help diagnose #RareDiseases earlier and faster.
👶 A TREAT panel for testing newborns genetically for rare diseases using just a few drops of blood from a heel prick
📱 An app to reliably track a patients' symptoms as a diagnostic aide
👉 https://link.europa.eu/GYhXKX
#IHITransformingHealth #HorizonEU #HorizonEurope

This August, we're launching our #SummerOfScience series again! Stay tuned to hear about our most impactful stories from the past year.
First up is the launch of Screen4Care's tools to help diagnose #RareDiseases earlier and faster.
👶 A TREAT panel for testing newborns genetically for rare diseases using just a few drops of blood from a heel prick
📱 An app to reliably track a patients' symptoms as a diagnostic aide
👉 https://link.europa.eu/GYhXKX
#IHITransformingHealth #HorizonEU #HorizonEurope

This August, we're launching our #SummerOfScience series again! Stay tuned to hear about our most impactful stories from the past year.
First up is the launch of Screen4Care's tools to help diagnose #RareDiseases earlier and faster.
👶 A TREAT panel for testing newborns genetically for rare diseases using just a few drops of blood from a heel prick
📱 An app to reliably track a patients' symptoms as a diagnostic aide
👉 https://link.europa.eu/GYhXKX
#IHITransformingHealth #HorizonEU #HorizonEurope

Sobi’s dealmaker CEO exits after global expansion

Why it matters: The departure provides a clear moment to assess one of the more consequential chief executive…
#Europe #EU #European #rarediseases
https://www.europesays.com/europe/108428/

https://www.europesays.com/africa/358767/ Tackling Rare Disease Through Genomics in Thailand and South Africa #Covid19 #Diagnosis #Genomics #MedicalGenetics #MolecularDx #News&Features #PrecisionMedicine #RareDiseases #SouthAfrica #topics

Rare disease drugmakers seek exclusion from Medicare pricing plans

WASHINGTON — Biotech companies are lobbying the Trump administration to exclude treatments for rare diseases from programs that…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #biotechnology #CMS #drugdevelopment #drugprices #Health #Pharmaceuticals #Policy #rarediseases #Research #STAT+ #WhiteHouse
https://www.newsbeep.com/us/775982/

Rare disease drugmakers seek exclusion from Medicare pricing plans

WASHINGTON — Biotech companies are lobbying the Trump administration to exclude treatments for rare diseases from programs that…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #biotechnology #CMS #drugdevelopment #drugprices #Health #Pharmaceuticals #Policy #rarediseases #Research #STAT+ #WhiteHouse
https://www.newsbeep.com/us/775982/

Polio survivor who was last American iron lung user dies at age 78

Dr Jessica Gray reveals why Americans are living longer Family medicine physician Dr. Jessica Gray explains that new…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Health #healthcarehouseofrepresentativespolitics #Lifestyle #rarediseases #Vaccines
https://www.newsbeep.com/us/758268/

Polio survivor who was last American iron lung user dies at age 78

Dr Jessica Gray reveals why Americans are living longer Family medicine physician Dr. Jessica Gray explains that new…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Health #healthcarehouseofrepresentativespolitics #Lifestyle #rarediseases #Vaccines
https://www.newsbeep.com/us/758268/

https://www.europesays.com/ie/578567/ MEP calls for Ireland to increase testing done on newborn babies for rare conditions – The Journal #BillyKelleher #Éire #Entertainment #EU #EuropeanParliament #HeelPrickTest #IE #Ireland #RareDiseases

ARPA-H invests $160 million to make custom gene editing routine

ARPA-H, the U.S.’ “moonshot” agency for health research, announced Thursday that it will spend up to $160 million…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #biotechnology #crispr #Geneediting #GeneTherapy #Health #hhs #rarediseases #STAT+
https://www.newsbeep.com/us/753035/

ARPA-H invests $160 million to make custom gene editing routine

ARPA-H, the U.S.’ “moonshot” agency for health research, announced Thursday that it will spend up to $160 million…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #biotechnology #crispr #Geneediting #GeneTherapy #Health #hhs #rarediseases #STAT+
https://www.newsbeep.com/us/753035/

How one father built a biotech, Grace Science, to save his daughter

Highlights Matt Wilsey has spent a decade and $70 million trying to develop a cure for his daughter…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #biotechnology #drugdevelopment #FDA #GeneTherapy #Health #Pharmaceuticals #rarediseases #STAT+
https://www.newsbeep.com/us/752485/

How one father built a biotech, Grace Science, to save his daughter

Highlights Matt Wilsey has spent a decade and $70 million trying to develop a cure for his daughter…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #biotechnology #drugdevelopment #FDA #GeneTherapy #Health #Pharmaceuticals #rarediseases #STAT+
https://www.newsbeep.com/us/752485/

Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)

First gene replacement therapy in the EU for broad population with SMA, including children two years and older,…
#Europe #EU #EuropeanCommission #CellandGeneTherapy #neuroscience #Novartis #rarediseases #ReimagineMedicine
https://www.europesays.com/europe/84540/

Calico targets longevity pathway with rare disease win

FDA Breakthrough Therapy Designation for fosigotifator highlights a mechanism that extends well beyond an ultra-rare childhood disorder. Calico…
#NewsBeep #News #Healthcare #AU #Australia #calico #drugdevelopment #FDA #FDAbreakthroughstatus #fosigotifator #Health #ISRIB #leukodystrophy #RareDiseases #VanishingWhiteMatterdisease
https://www.newsbeep.com/au/770666/

Calico targets longevity pathway with rare disease win

FDA Breakthrough Therapy Designation for fosigotifator highlights a mechanism that extends well beyond an ultra-rare childhood disorder. Calico…
#NewsBeep #News #Healthcare #AU #Australia #calico #drugdevelopment #FDA #FDAbreakthroughstatus #fosigotifator #Health #ISRIB #leukodystrophy #RareDiseases #VanishingWhiteMatterdisease
https://www.newsbeep.com/au/770666/

https://www.europesays.com/ie/562162/ Calico targets longevity pathway with rare disease win #calico #DrugDevelopment #Éire #fda #FDABreakthroughStatus #fosigotifator #Health #HealthCare #Healthcare #IE #Ireland #ISRIB #leukodystrophy #RareDiseases #VanishingWhiteMatterDisease

Sanofi (ENXTPA:SAN) Faces EU Antitrust Probe As Nexviazyme Trial Delivers Positive Data

Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million…
#France #FR #Europe #EU #Sanofi #antitrustinvestigation #EuropeanCommission #EuropeanEconomicArea #fluvaccine #Pompedisease #rarediseases #SimplyWallSt
https://www.europesays.com/france/43941/

Sanofi (ENXTPA:SAN) Faces EU Antitrust Probe As Nexviazyme Trial Delivers Positive Data

Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million…
#Europe #EU #antitrustinvestigation #EuropeanCommission #europeaneconomicarea #EuropeanUnion #fluvaccine #Pompedisease #rarediseases #Sanofi #SimplyWallSt
https://www.europesays.com/europe/82995/

Dangerous tick-borne virus spreading to more Americans, experts warn

NEWYou can now listen to Fox News articles! A rare and potentially fatal tick-borne illness currently spreading across…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Health #infectiousdisease #Insects #Lifestyle #outbreaks #outdoorlivingrealestatelifestyle #rarediseases #Viruses
https://www.newsbeep.com/us/733680/

Dangerous tick-borne virus spreading to more Americans, experts warn

NEWYou can now listen to Fox News articles! A rare and potentially fatal tick-borne illness currently spreading across…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Health #infectiousdisease #Insects #Lifestyle #outbreaks #outdoorlivingrealestatelifestyle #rarediseases #Viruses
https://www.newsbeep.com/us/733680/

Elixirgen Therapeutics and Nippon Shinyaku Enter into an Option Agreement for the Development and Commercialization of EXG-7001 for Duchenne Muscular Dystrophy

Elixirgen Therapeutics, Inc. BALTIMORE, June 26, 2026 (GLOBE NEWSWIRE) — Elixirgen Therapeutics, Inc., a clinical-stage biotechnology company developing…
#EuropeSays #Japan #JP #biotechnologycompany #Nippon #NipponShinyaku #rarediseases #Therapeutics
https://www.europesays.com/japan/49112/

Incyte (INCY) Wins EU Backing For Opzelura As Pipeline Data Builds Across Four Drugs

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply…
#Europe #EU #atopicdermatitis #EuropeanCommission #EuropeanUnion #globalcommunity #Incyte #individualinvestors #myeloproliferativeneoplasms #Opzelura #rareconditions #rarediseases #regulatoryupdates #treatmentguidelines
https://www.europesays.com/europe/80625/

Elixirgen Therapeutics and Nippon Shinyaku Enter into an Option Agreement for the Development and Commercialization of EXG-7001 for Duchenne Muscular Dystrophy

Elixirgen Therapeutics, Inc. BALTIMORE, June 26, 2026 (GLOBE NEWSWIRE) — Elixirgen Therapeutics, Inc., a clinical-stage biotechnology company developing…
#EuropeSays #Japan #JP #biotechnologycompany #Nippon #NipponShinyaku #rarediseases #Therapeutics
https://www.europesays.com/japan/47924/

Press Release: Sanofi appoints Paulo Fontoura as Global Head of R&D

Sanofi Winthrop Industrie Sanofi appoints Paulo Fontoura as Global Head of R&D Paris, June 22, 2026. Sanofi today announced the appointment of Paulo …
#France #FR #Europe #EU #Sanofi #ChiefExecutiveOfficer #ChiefMedicalOfficer #clinicaldevelopment #ExecutiveCommittee #ExecutiveVicePresident #Fontoura #GlobalHeadofResearch&DevelopmentPharma #HoumanAshrafian #rarediseases #therapeuticareas
https://www.europesays.com/france/40192/

Press Release: Sanofi appoints Paulo Fontoura as Global Head of R&D

Sanofi Winthrop Industrie Sanofi appoints Paulo Fontoura as Global Head of R&D Paris, June 22, 2026. Sanofi today announced the appointment of Paulo …
#France #FR #Europe #EU #Sanofi #ChiefExecutiveOfficer #ChiefMedicalOfficer #clinicaldevelopment #ExecutiveCommittee #ExecutiveVicePresident #Fontoura #GlobalHeadofResearch&DevelopmentPharma #HoumanAshrafian #rarediseases #therapeuticareas
https://www.europesays.com/france/39248/

18 children had illnesses so rare doctors were stumped. AI gave them answers

Love it or hate it, artificial intelligence has been integrated into humans’ everyday lives — and now, it…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Artificialintelligence #AI #ArtificialIntelligence #BostonChildren’sHospital #children #controversialtechnology #NBCNews #Neuromusculardisorders #patients #rarediseases #rareillnesses #Researchers #Technology
https://www.newsbeep.com/us/716030/

#VeteransAdministration #RareDiseases #Military

From Stars and Stripes: Veteran with rare muscle-wasting disease seeks VA recognition

https://www.stripes.com/veterans/2026-05-29/veteran-rare-disease-va-recognition-21816111.html

#VeteransAdministration #RareDiseases #Military

From Stars and Stripes: Veteran with rare muscle-wasting disease seeks VA recognition

https://www.stripes.com/veterans/2026-05-29/veteran-rare-disease-va-recognition-21816111.html

Scientists identify hundreds of ancient genes associated with human diseases

When a child develops kidney failure or a rare bone disorder, the cause can seem painfully immediate. It…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Science #ciliopathies #diseasegenes #Evolutionarybiology #healthnews #HumanGenetics #Kidneydisease #LECA #NewDiscoveries #osteopetrosis #proteininteractome #Proteomics #rarediseases #Research
https://www.newsbeep.com/us/672107/

𝗥𝗮𝗿𝗲 𝗱𝗶𝘀𝗲𝗮𝘀𝗲 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗱𝗲𝗺𝗮𝗻𝗱 𝗮𝗰𝗿𝗼𝘀𝘀 𝘁𝗵𝗲 𝗠𝗶𝗱𝗱𝗹𝗲 𝗘𝗮𝘀𝘁 𝗶𝘀 𝗲𝗻𝘁𝗲𝗿𝗶𝗻𝗴 𝗮 𝗵𝗶𝗴𝗵 𝗴𝗿𝗼𝘄𝘁𝗵 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗽𝗵𝗮𝘀𝗲!
The 𝗠𝗶𝗱𝗱𝗹𝗲 𝗘𝗮𝘀𝘁 𝗥𝗮𝗿𝗲 𝗗𝗶𝘀𝗲𝗮𝘀𝗲𝘀 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗠𝗮𝗿𝗸𝗲𝘁 is expanding as governments improve healthcare access, diagnostics, and specialty drug availability. Rising awareness and advancements in personalized medicine are reshaping patient care outcomes.
𝗥𝗲𝗮𝗱 𝗺𝗼𝗿𝗲: https://www.kenresearch.com/middle-east-rare-diseases-treatment-market
#Healthcare #RareDiseases #MiddleEast #PharmaIndustry

𝗥𝗮𝗿𝗲 𝗱𝗶𝘀𝗲𝗮𝘀𝗲 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗱𝗲𝗺𝗮𝗻𝗱 𝗮𝗰𝗿𝗼𝘀𝘀 𝘁𝗵𝗲 𝗠𝗶𝗱𝗱𝗹𝗲 𝗘𝗮𝘀𝘁 𝗶𝘀 𝗲𝗻𝘁𝗲𝗿𝗶𝗻𝗴 𝗮 𝗵𝗶𝗴𝗵 𝗴𝗿𝗼𝘄𝘁𝗵 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗽𝗵𝗮𝘀𝗲!
The 𝗠𝗶𝗱𝗱𝗹𝗲 𝗘𝗮𝘀𝘁 𝗥𝗮𝗿𝗲 𝗗𝗶𝘀𝗲𝗮𝘀𝗲𝘀 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗠𝗮𝗿𝗸𝗲𝘁 is expanding as governments improve healthcare access, diagnostics, and specialty drug availability. Rising awareness and advancements in personalized medicine are reshaping patient care outcomes.
𝗥𝗲𝗮𝗱 𝗺𝗼𝗿𝗲: https://www.kenresearch.com/middle-east-rare-diseases-treatment-market
#Healthcare #RareDiseases #MiddleEast #PharmaIndustry

𝗥𝗮𝗿𝗲 𝗱𝗶𝘀𝗲𝗮𝘀𝗲 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗱𝗲𝗺𝗮𝗻𝗱 𝗮𝗰𝗿𝗼𝘀𝘀 𝘁𝗵𝗲 𝗠𝗶𝗱𝗱𝗹𝗲 𝗘𝗮𝘀𝘁 𝗶𝘀 𝗲𝗻𝘁𝗲𝗿𝗶𝗻𝗴 𝗮 𝗵𝗶𝗴𝗵 𝗴𝗿𝗼𝘄𝘁𝗵 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗽𝗵𝗮𝘀𝗲!
The 𝗠𝗶𝗱𝗱𝗹𝗲 𝗘𝗮𝘀𝘁 𝗥𝗮𝗿𝗲 𝗗𝗶𝘀𝗲𝗮𝘀𝗲𝘀 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗠𝗮𝗿𝗸𝗲𝘁 is expanding as governments improve healthcare access, diagnostics, and specialty drug availability. Rising awareness and advancements in personalized medicine are reshaping patient care outcomes.
𝗥𝗲𝗮𝗱 𝗺𝗼𝗿𝗲: https://www.kenresearch.com/middle-east-rare-diseases-treatment-market
#Healthcare #RareDiseases #MiddleEast #PharmaIndustry

Soligenix advances rare disease innovation using platform science to expand its therapeutic pipeline and address unmet medical needs affecting millions. #RareDiseases #Biotech

Soligenix advances rare disease innovation using platform science to expand its therapeutic pipeline and address unmet medical needs affecting millions. #RareDiseases #Biotech

Soligenix advances rare disease innovation using platform science to expand its therapeutic pipeline and address unmet medical needs affecting millions. #RareDiseases #Biotech

Soligenix advances rare disease innovation using platform science to expand its therapeutic pipeline and address unmet medical needs affecting millions. #RareDiseases #Biotech

Soligenix reports strong Phase 3 HyBryte data for cutaneous T-cell lymphoma, with response rates exceeding expectations. Interim analysis could accelerate commercialization path. #Biotech #RareDiseases

Soligenix reports strong Phase 3 HyBryte data for cutaneous T-cell lymphoma, with response rates exceeding expectations. Interim analysis could accelerate commercialization path. #Biotech #RareDiseases

Soligenix reports strong Phase 3 HyBryte data for cutaneous T-cell lymphoma, with response rates exceeding expectations. Interim analysis could accelerate commercialization path. #Biotech #RareDiseases

Soligenix reports strong Phase 3 HyBryte data for cutaneous T-cell lymphoma, with response rates exceeding expectations. Interim analysis could accelerate commercialization path. #Biotech #RareDiseases

Soligenix publishes peer-reviewed HyBryte clinical data demonstrating safety and efficacy for cutaneous T-cell lymphoma treatment. Phase 3 trial interim results expected Q2 2026. #Biotech #RareDiseases